Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 11:35:77-79.
doi: 10.1016/j.jdcr.2023.02.022. eCollection 2023 May.

Botulinum toxin A as an alternative treatment for folliculitis decalvans

Simone R N G Neri  1 , Marcia R Franzolin  2 , Celia Luiza Petersen Vitello Kalil  3 , Nílceo S Michalany  4 , Alexandre O Michalany  5 , Marta O Domingos  2
Affiliations
Case Reports

Botulinum toxin A as an alternative treatment for folliculitis decalvans

Simone R N G Neri et al. JAAD Case Rep. .
No abstract available

Keywords: Botulinum Toxin A; Folliculitis decalvans; Staphylococcus aureus; alopecia.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Macroscopic (A) and trichoscopic (B) analyses of the patient's scalp show the presence of perifollicular hyperkeratosis, perifollicular erythema, hair thinning, and tufted hair.
Fig 2
Fig 2
Histological analysis of the lesional region. A and B, Horizontal sections showing perifollicular inflamation, perifollicular fibroplasia, and fused follicles. C, Vertical section showing degeneration and desquamation of the inner root sheath. (A,B, and C, Hematoxylin-eosin stain; original magnifications: A and B, 20×; C, 10×).
Fig 3
Fig 3
Macroscopic and tricoscopic analyses of the scalp. Comparison of pre- and posttreatment with botulinum toxin A.
See this image and copyright information in PMC

References

    1. Miguel-Gomes L., Rodrigues-Barata A.R., Molina-Ruiz A., et al. Folliculitis decalvans: effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up. Am Acad Dermatol. 2018;79(5):878–883. doi: 10.1016/j.jaad.2018.05.1240. - DOI - PubMed
    1. Otberg N., KJang H., Alzolibani A.A., Shapiro J. Folliculitis decalvans. Dermatol Ther. 2018;21:238–244. doi: 10.1111/j.1529-8019.2008.0024.x7. - DOI - PubMed
    1. Vañó-Galván S., Molina-Ruiz A.M., Fernandes-Crehuet P., et al. Folliculitis decalvans: a multicentre review of 82 patients. J Eur Acad Dermatol Venereol. 2015;29:1750–1757. doi: 10.1111/jdv.12993. - DOI - PubMed
    1. Zhou Y., Yu S., Zhao J., Xinyue Feng X., Zhang M., Zhao Z. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia. Biomed Res Int. 2020;2020:1501893. doi: 10.1155/2020/1501893. - DOI - PMC - PubMed
    1. Bunagan M.J., Banka N., Shapiro J. Retrospective review of folliculitis decalvans in 23 patients with course and treatment analysis of long-standing cases. J Cutan Med Sur. 2014;18:1–5. doi: 10.2310/7750.2014.13218. - DOI - PubMed

Publication types

LinkOut - more resources